1- UKPDS 35. Association of glycaemia with macrovascular and microvascular complications of Type 2 diabetes: prospective observational study. British Medical Journal 2000; 321: 405-412.
2- HAS. Principes de dépistage du diabète de type 2. ANAES / Service évaluation des technologies et service évaluation économique. Février 2003. http://www.has-sante.fr/portail/jcms/c_464100/principes-de-depistage-du…
3- Saaristo T, Peltonen M, Lindstrom J, Saarikoski L, Sundvall J, Eriksson JG, Tuomiletho J. Cross-sectional evaluation of Finnish Diabetes Risk Score : a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab Vasc Dis Res 2005; 2: 67-72.
4- Zimmet P, Thomas C. Genotype, obesity and cardiovascular disease- has technical and social advancement outstripped evolution? J Intern Med 2003; 254: 114-125.
5- Paulweber B, Valensi P, Lindstrom J, et al. Horm Metab Res 2010;42 (suppl 1):S3-236.
6- Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20:1183-1197.
7- American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33 (suppl 1): S62-S69.
En 5 points
Obésité : suivi d’un patient sous aGLP-1
Cas clinique
La fasciite nécrosante
Mise au point
La périménopause
Mise au point
La sclérose en plaques